Company Overview and News

Trade Halliburton Company with Confidence In Spite of Tepid Response to Earnings | InvestorPlace

1h investorplace
When the equity markets started the correction on Feb. 2, Halliburton Company (NYSE:HAL) stock had already started its own 7% slide off its earnings event. Then HAL tacked on another 15% with the rest of stocks on a slew of headlines from tariff wars to geopolitical unrest.
Upvote Downvote

Should Halliburton Earnings Have Been Better?

3h 247wallst
Halliburton Co. (NYSE: HAL) reported first-quarter 2018 results before markets opened Monday. The oil and gas services company posted adjusted diluted earnings per share (EPS) of $0.41 on revenues of $5.74 billion. In the same period a year ago, the company reported EPS of $0.04 on revenues of $4.28 billion. First-quarter results also compare to consensus estimates for EPS of $0.41 per share and $5.
Upvote Downvote

Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

2018-04-21 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Bahrain's Oil Find A Stroke Of Luck, But The Benefits May Have To Wait

2018-04-10 seekingalpha
The discovery of the new shale field off Bahrain's western coast might considerably increase its oil and gas reserves and contribute to the kingdom's economic and political stability in the long run, but the short-term risks remain high.
Upvote Downvote

7 Stocks to Buy That Are Leading the Way Higher

2018-04-05 investorplace
Stocks are rebounding strongly on Thursday ahead of Friday’s big non-farm payrolls report thanks to easing fears over U.S.-China trade tensions. Investors are realizing that opening tariff salvos are unlikely to be implemented. Instead, they are an opening gambit in what’s set to be a long and high-stakes negotiation.
Upvote Downvote

5 RBC Global Energy Best Idea Stocks to Buy Now

2018-04-03 247wallst
We cover almost all the top firms on Wall Street, and most do a fine job with overall market coverage. In addition to casting the proverbial broad net, some also are very proficient in covering specific sectors like energy. One of those companies is RBC, which is considered among the leaders in the coverage of the sector, and its Global Energy Best Ideas list is one of the reasons why.
Upvote Downvote

HAL / Halliburton Co. (Holding Company) HALLIBURTON CO - DEF 14A

Upvote Downvote

HAL / Halliburton Co. (Holding Company) HALLIBURTON CO - DEFA14A

Upvote Downvote

Just The Numbers... Plus: Frac Sand Companies

2018-03-29 seekingalpha
Frac sand entities take several forms: as divisions of large oilfield service companies, as part of public industrial sand companies or limited partnerships, and as private companies.
Upvote Downvote

Analyst Stays Very Bullish on 5 Top Oilfield Services Stocks

2018-03-19 247wallst
Despite an oil price that has stayed over $60 a barrel for most of 2018, the energy sector has been a weak performer this year. All this comes amid announcements that the United States is poised to become the world’s top oil producer as early as this year. Fast-growing U.S. production and restraints on oil production abroad have allowed the country’s oil production to surge to the top spot.
Upvote Downvote

5 Oil and Gas Giants Ready to Spill

2018-03-07 investorplace
U.S. equities are drifting lower in trading on Wednesday, hurt by deepening fears that a trade war will be unleashed by President Donald Trump’s desire to put tariffs on steel and aluminum imports as well as go after China on intellectual property and trade deficit concerns.
Upvote Downvote

At $46.42, Halliburton (HAL) a Sell

2018-03-01 investorplace
The Sell for Halliburton (HAL) this week is based on the latest relative pricing of its shares and stock market ratings. The Sell recommendation for Halliburton Co (NYSE:HAL) is the conclusion of a process of analysis that is proprietary which generated results that were below average in 6 areas: an economic sector ranked below average in attractiveness, an industry group ranked below average in attractiveness, a ranking in the company's sector that is in the middle third, ranking in its industry group that is in the middle third-below average, analytical scoring that is near average, and a mathematical computation of risk/reward that is unattractive.
Upvote Downvote

When Markets Correct, Many Fear, But Few Listen

2018-02-27 seekingalpha
When there’s not much to say, sometimes it’s prudent to not say anything at all. However, due to the volatility over the last month, it seems necessary to break the silence, evaluate what is currently occurring, and put some perspective on what is expected moving forward. Inevitably, when markets correct, something is changing and we ought to try and identify what that is.
Upvote Downvote

Deutsche Bank Has 3 Top Stocks to Buy Now for Rising Inflation

2018-02-27 247wallst
Any way you look at it, after years and years of almost no inflation pressure, the prices are starting to go higher, and that’s not totally a bad thing. Despite what some may think, on a measured basis, rising inflation often portends a better economy, and that would be a nice change after years of slow growth and almost zero increases in wages.
Upvote Downvote

Stocks To Watch: Investors Recharge After Soothing Fedspeak

2018-02-24 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 406216101